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Abstract
Background: Pulmonary embolism (PE) is a serious and potentially life-threatening complication
of venous thromboembolism and its diagnosis remains a challenge. The current gold standard to
confirm diagnosis of PE is multi-row computed tomography pulmonary angiography (CTPA) but
has limitations and alternative imaging modalities are being investigated. Point-of-care
ultrasound (POCUS) has been applied in the diagnostic process in PE but whether it can safely
replace the gold standard is of question.
Methods: A literature review was conducted to evaluate the sensitivity of single versus
multiorgan point-of-care ultrasound (POCUS) compared to CTPA in detecting PE in adult
patients.
Discussion: Several prospective observational studies exist investigating the use of single and
multiorgan POCUS but are inconsistent in the selection of subjects, diagnostic reference tests
used for comparison, criteria for PE diagnosis on POCUS and combinations of multiorgan
POCUS used. A limited number of studies exist for each of the combinations of multiorgan
POCUS investigated.
Conclusion: Both single organ and multiorgan POCUS have shown inferior sensitivity to CTPA
and cannot replace this diagnostic gold standard for PE. Triple multiorgan POCUS (lung, cardiac
and vascular) has shown the most promise thus far (sensitivity of 90%, specificity of 86%) and is
recommended for patients that cannot receive CTPA and an adjunct to help provide alternative
cardiopulmonary diagnoses, potentially reducing unnecessary radiographic imaging and may
help to improve the prediction rules in stratifying risk for patients clinical suspicion of PE. More
consistent research is needed to clarify the role and validity of POCUS in PE.
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INTRODUCTION
Pulmonary embolism (PE) is the most serious and potentially life-threatening
complication of venous thromboembolism (VTE). Pulmonary embolism requires prompt
diagnosis and treatment to prevent fatal sequalae. It is estimated that PE causes more than
50,000 deaths annually, has been reported to be the third leading cause of death in hospitalized
patients and the second most common cause of unexpected death in outpatients. 1,2 In patients
with fatal emboli, less than ten percent received appropriate treatment as the PE went
undiagnosed antemortem. When early diagnosis of PE is achieved, and anticoagulation therapy is
initiated immediately, it is highly effective with generally a favorable outcome; however, overall
prognosis can be variable depending on existing underlying conditions. 1,3
Pulmonary embolism may be lethal due to its various cardiopulmonary effects.
Obstruction of the pulmonary circulation can lead to infarction and hypoxemia due to necrosis of
lung parenchyma, atelectasis from surfactant depletion, decreased cardiac output, increased dead
space; bronchoconstriction may lead to wheezing and increased word of breathing.1,2
Additionally, massive thrombus may cause hemodynamic instability and right ventricular
failure.1
The most common cause of PE is VTE that originate in the deep veins of the lower
extremities and migrate to the pulmonary circulation. The signs and symptoms of PE can vary
depending on the size and location of the clot. In patients with proximal deep vein thrombosis
(DVT), approximately 50% will subsequently developed PE with most of these embolic events
being asymptomatic; alternatively, in those with symptomatic PE, up to 70% also had DVT upon
evaluation.1 Since both PE and DVT result from the same disease process, they are often
evaluated in tandem and share the same risk factors.
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Given the pathophysiology of VTE (including both DVT and PE), the signs and
symptoms of PE can be variable in presentation and severity which contribute to the difficulty in
making a timely and accurate diagnosis. According to the Prospective Investigation of
Pulmonary Embolism Diagnosis (PIOPED) study, patients with diagnosed PE most commonly
reported signs and symptoms of dyspnea, pleuritic chest pain or tachypnea; however, other
findings may include cough, leg pain and/or a positive Homan’s sign, hemoptysis, palpitations,
wheezing, angina, tachycardia, temperature, rales, third or fourth heart sound, accentuated S2
heart sound, pleural friction rub and cyanosis.1 The variation in clinical presentation of PE
remains a main factor in missed PE diagnosis and requires clinicians to maintain a high index of
suspicion for PE to ensure that it remains in their broad cardiopulmonary differential and work
up.1,3,4
Another factor complicating evaluation of PE is that it cannot rely on one diagnostic test.
Current guidelines recommend a strategy that includes a combination of clinical assessment as
well as laboratory and imaging studies for diagnosis. A definitive diagnosis of PE requires
imaging, but the use of clinical probability assessment tools combined with a D-dimer blood test
help to determine if imaging should be pursued.2,3,5 Currently, the reference imaging test to
initially diagnosis PE is computed tomography pulmonary angiography (CTPA) which has
demonstrated a sensitivity of 96-100% and a specificity of 97-98%.3-6 However, despite the
increased use and availability of CTPA, the mortality of PE has not significantly improved.2,5
Furthermore, CTPA has limitations and cannot be used in every patient case. 5,6 Given the
drawbacks to CTPA, alternative diagnostic strategies for PE have been explored.
The use of bedside or point-of-care ultrasound (POCUS) to aid in diagnosis of PE has
been described as early as the mid-1960s.7 In these early, small studies, the use of lung
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ultrasound at the bedside may have accurately diagnosed PE lesions in greater than 90% of
cases.4,7 A similar study repeated around 1990 validated these results also reporting a diagnostic
accuracy of 90%.8 However, the routine use of POCUS was likely not employed at the time due
to the lack of large, prospective trials. With more recent improvements in ultrasound technology
over the last approximately 20 years, ultrasound has been increasingly used by practitioners,
other than radiologists and certified sonographers, in various diagnostic and procedural aspects
of patient care. Clinical locations in which POCUS has been more commonly utilized are those
that rely on succinct and timely diagnosis of acute presentations – such as the emergency
department, acute care units and the perioperative setting.9
Given the complexity and time sensitivity factors in diagnosing PE as well as the
emergence in use and availability of POCUS, it is logical to question if the sensitivity of POCUS
now could rival that of CTPA to help assist in early detection of PE in adult patients presenting
with clinical suspicion of the disease. In order to explore this question, the initial objectives will
be to review the current recommendations and limitations for diagnostic management of PE,
what POCUS is as well as how it is currently is utilized to evaluate acute pulmonary pathology.
Secondly, a review of the current literature on how POCUS compares to CTPA for diagnostic
accuracy will be explored.
BACKGROUND
Challenges in Diagnostic Management of PE
Given the complexity in diagnosing PE but need for efficient and systematic evaluation,
algorithms have been developed to help standardize the work up for this disease (see Figure 1 for
an example of such an algorithm). The initial evaluation in proposed algorithms often begin with
a clinical assessment to help determine the probability of PE and decrease the amount of
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unnecessary and imaging. As previously discussed, signs and symptoms alone can be nonspecific to PE; however, when combined with other risk factors or symptoms or included in
prediction rules, the risk stratification for true PE incidence can be better estimated. The most
widely used prediction rules are the Wells and Geneva rules (see Table 1). Meta-analyses have
validated the use of both tools as well as reported their diagnostic performance to be
comparable.10 Some criticism has been made that items for these scoring systems may subjective
rather than objective (e.g., “alternative diagnosis less likely than PE” or “clinical signs of DVT”
criteria in Wells score) leading to increased additional and unnecessary diagnostic testing. 11
If a patient is determined to have an increased probability based on initial clinical
assessment, the next test in diagnostic PE algorithms is usually to obtain a D-dimer blood test.
Plasma D-dimer is a product of the degradation of cross-linked fibrin by plasmin and typically
increases in the presence of thrombus. 1,3,10 The D-dimer test is used as a test of exclusion given it
has high sensitivity but cannot be used solely for diagnostic purposes with a lower specificity.
One of the most commonly used D-dimer tests is the rapid quantitative enzyme-linked
immunosorbent assay (ELISA). D-dimer ELISA levels of 300-500 mcg/L have shown to have a
sensitivity of 95% with a specificity of 40-45%.1,3,10 Given D-dimer results do not have 100%
sensitivity and low specificity, their use should be reserved for those patients with non-high
probability risk to rule out PE.
The lower specificity of D-dimer in relation to PE diagnosis can be attributed to its
elevated presence in other conditions such as cancer, inflammation, infection, chronic kidney
failure, pregnancy, trauma, postoperatively, previous VTE, and advancing age. Given the
number of elderly patients that may experience VTE, an alternative age-adjusted D-dimer cutoff
calculation was developed for patients over the age of 50 (multiply the age of a patient by 10)
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while the recommendation is to continue to use the limit of 500 mcg/L for patients younger than
50 years. The age-adjusted D-dimer cutoff has been shown to have a five-fold increase over the
conventional cutoff ranges and is now part of the American College of Physicians Best Practice
Advice to include in the evaluation of patients with suspected PE. Currently, no other proposed
and validated adjusted cutoff values exist for other conditions that affect D-dimer levels in
patients prone to VTE (e.g., pregnancy). The use of D-dimer should only be used in conjunction
with an unlikely or low clinical probability assessment; if used in these cases and a positive
result occurs, the clinician should be prepared to pursue appropriate diagnostic imaging. The use
of D-dimer is redundant in those with high probability assessment of PE. 3,10
Historically, the gold standard for confirmation of PE after a positive D-dimer result or
high clinical suspicion was to then obtain imaging with pulmonary angiography (PA). This
method is invasive as it requires right heart catheterization and contrast injection and is usually
less available given it requires expertise to complete.3 Alternatively, a diagnostic test that has
been historically used in the evaluation of PE is ventilation-perfusion lung scintigraphy
(commonly referred to as a V/Q scan). A V/Q scan indirectly diagnoses a PE by identifying
areas where there is a mismatch in the perfusion and ventilation of lung tissue.10 However, in
clinical trials, a drawback to V/Q scans is that it has been shown to have high number of
inconclusive results when compared to other more recent diagnostic imaging modalities such as
CTPA. 3,10,12
The additional use of venous ultrasonography, also referred to as compression ultrasound
(CUS), is yet another first-line test employed in the evaluation of PE. Given the previously
described association between DVT and PE, the presence of lower extremity DVT must be
evaluated when PE is suspected. Proximal lower extremity DVTs more often are associated
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with PE and the inability to compress the common femoral veins, popliteal veins or both is
diagnostic for a first episode of proximal DVT. This test has been reported to have a sensitivity
of 94% and specificity of 98% for proximal DVT evaluation but is less accurate in distal,
recurrent or asymptomatic thrombi.1,3 A positive lower extremity CUS test supports making a
diagnosis of PE without pursuing further imaging, and initiating early anticoagulation therapy.10
However, not all patients with PE have DVT and this test cannot be used to exclude a diagnosis
of PE.
With the development and availability of CTPA around the 1990s, this modality has
replaced PA and V/Q scanning and become the initial gold standard test to diagnose PE. 3,10 The
modality of CTPA requires injection of iodinated contrast medium in order to produce direct
visualization of pulmonary arteries. As CTPA technology has evolved from a single to multidetector row technique, so has its diagnostic accuracy with multi-row imaging (at least four-row)
now demonstrating a sensitivity of 96-100% and specificity of 97-98%.2,3 The use of multidetector row CTPA as a single imaging test to safely diagnose or rule out PE has been
established by multiple prospective outcome studies. 3,10 Furthermore, in those cases in which
CTPA can rule out PE, this imaging modality has been shown to have the added benefit of
providing an alternative diagnose for the underly cause of symptoms.1,3
Several limitations for the use of CTPA exist. Although this imaging modality has been
shown to have both high sensitivity and specificity, there is still potential for false-negative
results in those patients evaluated to have high clinical probability. 3 It has also been reported that
CTPA is the most sensitive for detecting proximal (central) PE but may be less sensitive for
detecting peripheral (distal) PE.3 Furthermore, CTPA is contraindicated for those patients who
have significantly impaired renal function or are pregnant. 3,12 In patients with mild to moderate
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allergy to contrast media, CTPA is relatively contraindicated but may still be pursued if patients
are pre-medicated with a regimen of corticosteroids with or without histamines.13 Another
disadvantage of CTPA is the radiation exposure which has been reported to range from three to
five millisieverts (mSv), equating to an estimated risk of 450-750 excess cancer deaths per
million exposed to a single CTPA for suspected PE.3 This imaging modality also requires the
patient to be stable enough to be transported to the radiology department and requires specialized
staff to perform which may not always be available at all institutions. 3
With the increased utilization of CTPA, an increase in PE diagnosis has been observed
but without a corresponding decrease to mortality.2,5,6 Furthermore, the number of patients
receiving CTPA with negative results has significantly increased indicating that a number of
patients are put at increased risk receiving unnecessarily increased radiation exposure and subject
to side effects of contrast media.6 One theory to explain this observation is that with the
availability of CTPA, there may be a lower threshold to pursue diagnostic imaging resulting in
identification and initiation of anticoagulation therapy for more small, subsegmental (distal) PE
that maybe would not have been fatal to begin with. Controversy exists if the benefit outweighs
the risk in pursuing treatment of these small emboli as currently there is limited literature
investigating this issue. Currently, a prospective, observational cohort study is underway to help
answer the question of if it is safe to withhold treatment in those patients with subsegmental PE
and negative bilateral lower extremity CUS (NCT01455818).10,14
With all testing options available in the evaluation for PE, CTPA currently remains the
preferred initial imaging modality for confirmation of this disease. In those patients with
negative or indeterminate CTPA results but high clinical suspicion of PE, controversy exists as
to whether patients should be further evaluated by CUS, V/Q scans and/or PA.10 However, these
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tests still have a role for patients with suspected PE and in which CTPA may be unavailable or
contraindicated.
Despite the currently available diagnostic tests and protocols that exist for the evaluation
of PE, this complex condition continues to be underdiagnosed and have a high mortality rate.
Given the above described challenges in evaluating PE, other imaging modalities have been
explored to help improve the sensitivity, efficiency and inclusivity in the diagnostic approach to
PE.
What is POCUS?
Point-of-care ultrasound refers to the use of portable ultrasonography at the bedside by
non-radiology physicians and advanced practice providers for the care of acute and critically ill
patients. The most common application of POCUS has been in the emergency department (ED)
and in intensive care units (ICUs) where efficient evaluation is crucial to help determine possible
pathology and a strategy for management and intervention.15
Point-of-care ultrasound differs from the conventional, consultative ultrasonography
evaluation in several ways. First, the examination is performed by the managing clinician rather
than skilled technicians completing the ultrasound exam with consulting radiologists or
cardiologists interpreting the results. This clinician is responsible for all interpretation as well as
integration of the images obtained into the management of the patient. This oftentimes is of
benefit as information obtained can immediately be used to help narrow a differential diagnosis
and direct patient care.9,15 Second, the POCUS examination is not comprehensive and usually is
used to answer a specific question about a condition or help assist with procedural goals.
Although POCUS can be a useful exam itself, it is crucial for the safety of patients that clinicians
recognize when POCUS does not provide definitive evidence and standard imaging or
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consultative ultrasound examination is required to ensure accurate diagnosis in complex or
critical cases.15 The location and timing in which these two evaluations may also differ. Often
consultative ultrasonography is postponed until a patient is hemodynamically stable and may be
done at the bedside or require the patient to be transported to the echocardiology and/or
radiology department; whereas POCUS has the advantage of always being performed at the
bedside and, therefore, the stability of the patient does not preclude completion of the
examination.9,15
The use of POCUS has been gaining increased acceptance as a supplement to the
physical examination of a patient. The American Academy of Family Physicians has published a
document for recommended curriculum guidelines for POCUS and states that when POCUS is
utilized with the physical exam it, “…offers additional anatomic, functional, and physiologic
information to guide patient care.”16 In 2012, the Accreditation Council for Graduate Medical
Education (ACGM) selected POCUS as one of its required competencies to the curriculum for
emergency medicine residents.16 Many medical institutions have also already incorporated
POCUS training into their curriculum as an adjunct to the physical exam. Given this imaging
modality is being increasingly used by clinicians, several national and international organizations
now offer training and certifications programs for various types of POCUS for those that have
not yet had POCUS education included in their curriculum. Aside from emergency medicine,
standards are still being developed for other areas of practice. 9
POCUS in Cardiopulmonary Pathology
The use of POCUS has wide-ranging applications. Multiple terms have been proposed
for various more specific types of POCUS and this paper will focus on those described
specifically for cardiopulmonary use. Terms and abbreviations for variations of single organ
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POCUS that have been proposed include: lung ultrasonography (LUS), thoracic or transthoracic
ultrasonography (TUS; including include lung, pleura and/or heart), vascular (CUS), cardiac
(including echocardiography) and multiorgan ultrasound (which includes ultrasound in two or
more of the aforementioned locations).15 In addition to the previously described use of CUS for
vascular POCUS, various protocols have been developed to help standardize the use of bedside
ultrasound in other cardiopulmonary areas to guide clinicians for observed signs to hone in on
pathology. Examples of proposed algorithms include the bedside lung ultrasound in emergency
(BLUE) protocol and the focused cardiac ultrasound (FOCUS).15,16
Thoracic and LUS are currently utilized by clinicians to help differentiate common
causes of acute cardiopulmonary compromise such as pneumonia, pulmonary edema, pleural
effusion, and pneumothorax in critically ill patients.15 The diagnosis of PE has also been
included in this list in some studies given the overlap of presenting symptoms and inclusion in
the differential diagnosis for these conditions. The use of TUS has been reported to be similar or
superior to chest radiography in detecting pneumothorax, pneumonia and consolidation in
pulmonary effusion.15 The BLUE protocol, for example, contains an algorithm that helps guide
clinicians in determining the etiology of acute respiratory failure through examination of
anterior, lateral and posterolateral points on the thorax bilaterally as well as the addition of CUS
(multiorgan POCUS).17 When this protocol is used, POCUS provided a correct diagnosis for the
underlying etiology of respiratory failure in 90.5% of cases – including in 21 cases of PE.17,18,19
Ultrasound has potential for improving the diagnostic evaluation of PE given when
vascular occlusion occurs, the resulting atelectasis with extravasation of blood or infarction of
lung tissue results in consolidation in peripheral lung parenchyma and can be visible on lung
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ultrasound.2 Ultrasound characteristics that are associated with some cardiopulmonary causes of
respiratory compromise are summarized in Table 2.15,17,20
The use of the BLUE protocol has been shown to significantly reduce the time from
admission to diagnosis to initiation of treatment for the underly cause of respiratory distress in
the ED.18 Therefore, this illustrates that POCUS is already being applied to help narrow down the
differential diagnosis for presentations of respiratory compromise and in some cases may be of
use to help gather information that may help find alternative etiology to rule out PE versus lead
to an expedited diagnosis.
Pulmonary embolism can also have cardiac manifestations that lend to detection on
cardiac ultrasound. Historically, the presence (or absence) of right ventricular (RV) strain has
been viewed on transthoracic echocardiography (TTE) and can help differentiate the severity of
PE (i.e., massive versus lower risk) and predict mortality.18 However, cardiologists typically
perform TTE and therefore this examination may not be available or have delays when needed.17
The FOCUS protocol has been proposed to help standardize the characteristics of RV strain on
ultrasound and may include the following: the measurement of tricuspid annular plane systolic
excursion (TAPSE; measurement <17 mm), RV enlargement with comparison to left ventricle
(LV) size (RV to LV ratio >1); or presence of septal flattening, tricuspid regurgitation (on color
Doppler), or McConnell’s sign (RV hypokinesis with apical sparing).21,22,23 In a retrospective
chart review study by Taylor et al in 2013, the authors evaluated the ability of ED providers to
utilize a point-of-care FOCUS exam in patients with suspected PE. Of the 161 patients with
confirmed diagnosis of PE by either CT (n=127), V/Q study (n=19) or clinically if evidence of
DVT found on CUS (n=6) that received a FOCUS exam, RV strain found by ED providers was
the, “single most important prognostic factor found to predict adverse outcomes.”21 This study,

POCUS vs CTPA and PE
15

although did not compare the sensitivity of FOCUS in diagnosing PE, demonstrates that the use
of cardiac POCUS likely has a role in the urgent evaluation of PE where consultant cardiology
ultrasound is not readily available.
Literature Review: Sensitivity of POCUS compared to CTPA for PE detection
In order to understand the role POCUS may play in the evaluation of PE, a comparison
to the currently accepted gold standard diagnostic test of CTPA must be explored. Given that
POCUS has been used in both single (TUS, LUS, cardiac ultrasound/echocardiography and
vascular) and multiorgan ultrasound applications, literature pertaining to each will be evaluated
with a focus on TUS/LUS and cardiac single organ ultrasound as CUS has been previously well
studied and accepted in the use for DVT evaluation.10
Single organ POCUS: thoracic and lung
Thoracic ultrasound encompasses imaging of both the lung and pleura and often the name
is used interchangeably with LUS or chest ultrasound when described in the literature. One of
the earlier, small studies conducted to evaluate TUS was done by Mathis et al in 1993 who
sought to investigate results observed by the previously reported early studies from the 1960s.7,8
In this study, 58 patients who presented with symptoms concerning for PE were consecutively
enrolled and received an initial “chest ultrasonography” examination. The diagnosis of PE was
verified using ventilation-perfusion lung scanning and PA and reported ultrasound to have a
sensitivity of 98%, a specificity of 60% and an overall accuracy of 90% in PE diagnosis. 8
Although this study used a diagnostic method different from this paper’s research question, it is
worth mention for comparison, as this group of investigators went on to later do a larger, similar
study using CTPA (to be discussed later in this paper). Given the use of CTPA was not routinely

POCUS vs CTPA and PE
16

available and used in studies until the twenty-first century, the research in this paper will focus
on those studies published after the year 2000.
The predominance of studies that exist for the use of single organ TUS/LUS in the
evaluation of PE include small, prospective, observational studies (see Table 3 for a summary of
studies reviewed). Four studies exist earlier in the twenty-first century comparing TUS to singlerow CTPA.4,24,25,26 Reissig et al began comparing CTPA to TUS in two separate, small
observational studies that yielded similar results in 2001 and 2004.4,24 In 2001, 69 patients with
symptoms suspicious for PE were consecutively enrolled compared to 62 patients in the 2004
study. In both studies, single-row CTPA was used as the reference diagnostic test but was only
able to confirmed the diagnosis of PE in 46-50% of the suspected PE cases alone; the remaining
patients required additional testing for diagnosis confirmation (e.g., V/Q scan, CUS,
echocardiography or D-dimer). 4,24 The overall incidence of PE in the two studies was 64% in
2001 and 63% in 2004. It was disclosed in the 2001 study that only 62 of the 69 subjects
received CTPA exams for evaluation of PE and noted that the modality was “unavailable” for
unspecified reasons. 4 It was also noted in this study that an additional 138 patients had suspected
PE during the study period, but these patients were not included in the study as TUS was “unable
to be performed” (again, reasons for inability to complete ultrasound in these patients was not
specified).4 This method of subject selection in the 2001 Reissig et al study may lend to
inaccurate representation and bias of the patient population included. Additionally in this study,
of those patients with a “correct positive” diagnosis of PE on TUS (n=35), only 32 of them
received CTPA exam for comparison with the other patients still having a diagnosis consistent
with the alternative criteria.4 While this makes comparison of TUS to the standard diagnostic
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imaging for PE difficult, it may support that when contrast-enhanced imaging is unavailable, the
use of TUS may be helpful in evaluating PE.
When TUS was compared to all patients with confirmed PE diagnoses in the Reissig et al
2001 study, the detection of was similar to the 2004 study with a reported sensitivity of 80% and
77%, respectively, and a specificity of 92% and 91%, respectively.4,24 It should be noted that
historically the sensitivity of single-row CTPA alone in other studies has been reported to be
only 76% in the diagnosis of PE.3 While the sensitivity observed in these two studies by Reissig
et al are comparable or exceed previously reported sensitivity for single-row CTPA, it remains
inferior to more recent advancements in multidetector CTPA.
An additional small pilot study was conducted by Mohn et al in 2003 with the goal to
investigate the diagnostic performance of TUS in those patients presenting with suspicion of
PE.25 This study a similar validation strategy as Reissig et al with consecutively enrolling
patients and comparing the results of TUS to diagnostic references tests performed by clinicians
blinded to each other’s exam. Diagnostic criteria for PE included: CTPA with evidence of filling
defects or occlusion of pulmonary arteries outlined by contrast media (however, details of the
type of CT were not specified in the study to compare to the above two studies), high clinical
probability and V/Q scan, DVT on CUS and abnormal lung scan or PA. 25 A total of 74 patients
were enrolled with 31 patients (42%) confirmed to have a diagnosis of PE based on the various
reference tests25. Of those enrolled, CTPA was performed in 52 patients and confirmed the
diagnosis of PE in only 15 subjects for comparison to TUS.25 Therefore, in the 22 patients
reported to have a had a PE positive TUS result, only 68% of them were confirmed by CTPA in
this study. Overall, when TUS was compared to all reference diagnostic tests, the sensitivity was

POCUS vs CTPA and PE
18

reported to 71% and a specificity of 77%.25 It was concluded by the authors that TUS alone was
not an accurate overall test to confirm nor exclude the diagnosis of PE. 25
One of the largest studies available to evaluate single organ TUS use in PE evaluation
was subsequently conducted by Mathis et al in 2005.26 In their prospective, multicenter study of
TUS in the evaluation of PE, they also used single-row CTPA as their reference test of choice to
initially confirm diagnosis of PE. Similar to Reissig et al, if imaging results were negative or
inconclusive, they alternatively used clinical algorithms for diagnosis and comparison to
TUS.4,24,26 The TUS exam in this study was differentiated into four categories based on the
number of lesions and/or signs of pleural effusion detected: PE- confirmed, PE-probable, PEpossible and normal. A total of 352 patients were included in the analysis of this study with 194
(55%) diagnosed with PE; of these, 169 patients (87%) were diagnosed with PE using CTPA.
When TUS categories were compared to CTPA, the PE-confirmed and PE-probable groups had a
combined sensitivity of 74% and specificity of 95% and an overall accuracy of 84%. It was also
reported that TUS detected significantly more lesions while demonstrating a congruence with the
size and location of those lesions found on CTPA. The authors speculated that TUS may have
the capability to detect a larger number of smaller lesions compared to CTPA.26 However, this
may or may not be an advantage to TUS over CTPA when considering the controversy
surrounding if all lesions require anticoagulation therapy.
As imaging technology advanced to include multi-row CTPA, additional studies were
performed to compare the performance of TUS to this evolving reference test. Four subsequent
studies were published between 2010 and 2018 comparing TUS in a similar research design to
the above four earlier studies, but this time utilized multi-row detector CTPA in all patients with
suspected PE.27-30 In 2010, Pfeil et al found that in 33 patients presenting with symptoms of PE
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and received both multi-row CTPA and TUS, 10 patients were diagnosed with PE by CTPA but
only 7 patients had both positive TUS and CTPA, reporting a sensitivity of TUS to for detecting
PE to be only 70% with a specificity of also 70%.27 This study reported the lowest sensitivity of
all single organ TUS studies reviewed for this paper but likely can be attributed to the fact that a
more sensitive reference test was used in this study compared to earlier studies and/or the very
small sample size. Comert et al conducted a similar study in 2013 with a somewhat larger
sample size (n=50); of which 60% were diagnosed with PE by multi-row CTPA and 27 patients
had a true positive TUS (54%).28 However, this group did sub-analysis dividing subjects into
subgroups based on the quality of TUS findings. They reported a sensitivity of 43% and
specificity of 75% for those patients who had two or more characteristic lesions (wedge,
triangular or rounded) with or without pleural effusion, sensitivity of 70% and specificity of 65%
for those patients with the one characteristic lesions plus pleural effusion and a sensitivity of
90% and specificity of 60% when the two groups were combined.28 Furthermore, in a
prospective observational study in 2017 by Acar et al enrolling 100 patients, 38 patients received
multi-row CTPA confirming diagnosis of PE.29 Of the patients that had positive signs for PE
(three or more B-lines in one area, one or more signs of wedge lesions or pleural effusion), it was
those with the characteristic wedge sign alone for detection of PE on ultrasound showed the
highest sensitivity of 42% with a specificity of 98% (data for groups combined were not
analyzed).29 These two studies illustrates that the criteria for obtaining a positive TUS/LUS for
diagnosing PE likely needs standardization for the characteristics found on ultrasound to help
optimize the sensitivity of the test when used. Furthermore, it illustrates that TUS has lower
specificity and a negative examine alone cannot be used to rule out the diagnosis of PE.
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Lastly, the most recent study conducted by Ghanem et al in 2018 investigated the use of
TUS compared to multi-row CTPA in diagnosing PE but also additionally looked at how grayscale TUS compared to doppler ultrasound.30 The criteria for a positive TUS finding used was
similar to Comert et al and Pfeil et al.29,30 A total of 60 patients with suspected PE received TUS
and CTPA; of those, 40 patients were confirmed to have a diagnosis of PE with multi-row CTPA
and 33 patients had evidence of PE on grey-scale TUS yielding a sensitivity of 82% with a
specificity of 90%. Additionally, it was noted that the addition of color doppler only increased
the specificity to 95% while decreasing the sensitivity to 80%.30
Two recent meta-analyses exist published investigating the role of TUS and/or LUS in
the diagnosis of PE.31,32 In 2013, Squizatto et al attempted to evaluate the diagnostic accuracy of
LUS by selecting studies in which any patient with suspected PE received LUS plus “at least, an
imaging test” and evaluated the sensitivity and specificity of LUS; no study was excluded based
on the type of reference standard used and there was no restriction to language. 31 Ultimately, ten
studies were included (two of which were in German) that spanned the years 1990-2010.31
Therefore, four of the studies occurred prior to the year 2000 and four did not utilize CTPA for a
reference test comparison in diagnosing PE (alternatively used PA, V/Q scans or autopsy). 31 Of
the other six studies conducted in 1999 or later, one used MRI as the reference test, four used
“composite” reference tests that included CTPA (single-row) and/or historical standards
described previously and only one study (from 2010) used multi-row CTPA for confirmation of
PE diagnosis. Cumulatively, PE was diagnosed in 507 patients and LUS showed positive
symptoms of PE in 417 patients reporting a pooled sensitivity of 87% (95% CI, 80-92%);
additionally, LUS was reported to be negative (normal) in 324 of the 380 patients who had PE
negative diagnostic tests resulting in a pooled specificity of 82% (95% CI, 71-89%).31 However,
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given this study included variable diagnostic reference tests and potentially with lower
sensitivity, the reported diagnostic accuracy of LUS in this analysis may be inflated.
In 2015, Jiang et al recognized weaknesses in the meta-analysis by Squizatto et al and
repeated a systematic review and metanalysis that included 13 studies spanning the years 19902013 and 1356 subjects.32 However, Jiang et al also performed sub-analysis for those studies
performed prior to the year 2000 versus post-2000 to minimize the influence single versus multirow CPTA may have had in the comparison of LUS to CTPA. When all studies were analyzed
together, the pooled sensitivity of LUS in diagnosing PE was 85% (95% CI, 78-90%) with a
specificity of 83% (95% CI, 73-90%).32 When sub-analysis was performed on the five studies
conducted prior to the year 2000, the pooled sensitivity was 94% (95% CI, 89-96%) and
specificity was 74% (95% CI, 61-85%); comparatively, in those studies performed after the year
2000, the pooled sensitivity was 77% (95% CI, 70-83%) and specificity was 88% (95% CI, 7894%).32 This supports the previously stated hypothesis that earlier (less sensitive) diagnostic
methods for PE likely falsely inflated the accuracy of LUS and/or TUS in evaluating PE.
Single organ POCUS: cardiac
The use of cardiac POCUS (echocardiography) to evaluate for RV dysfunction through a
FOCUS exam has been reported to increasingly help ED providers gain information to
differentiate the symptoms of chest pain or dyspnea.22 Four studies prospective, observational
studies were found examining the use of cardiac POCUS alone in diagnostic work up for
PE.22,23,33,34 In three of these studies, single cardiac POCUS was evaluated in comparison of the
use of multiorgan POCUS and details of the studies will be discussed elsewhere (see
“Multiorgan POCUS”) as well as summarized in Table 3.23,33,34 The results of these three studies
showed high variability in sensitivity of cardiac POC ranging from 48-92% for the diagnosis of
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PE.23,33,34 Additionally, Daley et al investigated the use cardiac POCUS in a prospective,
observational study in which a convenience sample included 150 patients who were being
evaluated for suspected PE.22 Subjects included were those that had CTPA and were able to have
a FOCUS exam completed when ED clinicians were available to do so (convenience sample).
The authors in this study focused on the sensitivity of the TAPSE portion of the FOCUS exam,
how varying the TAPSE measurement affected sensitivity as well as how TAPSE compared to
other components of the exam. 22 A total of 32 patients had PE diagnosed by CTPA but did not
specify the number of patients from the total sample that had positive FOCUS exams. The
authors reported that a FOCUS exam using a TAPSE of 20 mm had the highest sensitivity of
72% compared to 56% when the standard recommendation for a TAPSE of 17 mm was used; for
all other parameters usually included in a FOCUS exam (i.e., RV enlargement, “D” sign or septal
flattening, tricuspid regurgitation or McConnel’s sign), the sensitivity ranged from 13-43% (the
authors did not report the overall sensitivity for all components of the FOCUS exam).22
However, it was noted in post hoc analysis that when those patients who were diagnosed with a
PE and initially presented with symptoms of tachycardia and/or hypotension (n=17), the
sensitivity of TASPE alone in the FOCUS exam was 94% and 100% when all components were
combined in analysis for these patients.22 In the other three studies reviewed, only Dwyer et al
included TAPSE in their FOCUS evaluation and also reported this criteria to have the highest
sensitivity out of the FOCUS components but still remained low at only 37%.23 Furthermore, in
the study by Mansencal et al they also reported a higher sensitivity of a cardiac POCUS exam
(72% compared to 55%) for patients diagnosed with PE that presented with symptoms of
dyspnea.33 These findings highlight the importance of evaluating the components of protocols
used in single organ POCUS as well as their utility in specific symptom presentations of PE.
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Multiorgan POCUS
The comparison of the aforementioned single organ ultrasound studies highlights the
variable and suboptimal sensitivity that exists with single organ POCUS. It further illustrated
that even when single organ ultrasound use is intended, oftentimes additional ultrasound
modalities, namely CUS and cardiac ultrasonography (echocardiography), have been utilized as
well to help ensure accurate diagnosis of PE or when CTPA is inconclusive, unavailable or
contraindicated. Given this trend, additional studies have gone on to investigate if combined use
of various single organ modalities will improve the diagnostic accuracy of POCUS. Studies of
multiorgan POCUS exist as early as 1998 but, given more sensitive diagnostic confirmatory
imaging for PE was not available at this time, this paper will focus on those multiorgan POCUS
studies only including comparison with CTPA.35
The term “triple” POCUS has been coined to describe one modality of multiorgan
POCUS that includes the use of combined LUS/TUS, vascular (including CUS and/or IVC
evaluation) and cardiac ultrasound. Two studies were found investigating the use of triple
POCUS6,13 but only one evaluated the sensitivity and specifically for use of triple POCUS in PE
diagnosis. Nazerian et al conducted a multicenter, blinded, prospective accuracy study in 2014
comparing the use of triple POCUS (LUS, cardiac and vascular/CUS) to confirmed diagnosis of
PE by multi-row CTPA in 357 patients presenting with clinical symptoms suspicious for PE.6 Of
the total number patients enrolled, 133 had a positive multiorgan POCUS exam and 99 of those
patients had a confirmed diagnosis of PE yielding a sensitivity of 90% and a sensitivity of 86%.
The authors of this study also provided sub-analysis for each single system POCUS and reported
the following for sensitivity and specificity: 61% and 96% for LUS alone, respectively; 33% and
91% for cardiac alone, respectively; and for vascular (CUS) 53% and 98%, respectively.6 This
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study combining single and multiorgan POCUS comparisons, illustrates previous conclusions
that single organ POCUS is insufficient alone for diagnosis of PE but that the use of triple
POCUS may increase the potential of this modality for sensitive diagnosis of PE.
More recently, Zanobetti et al attempted to evaluate the use of multiorgan POCUS (LUS,
cardiac) in patients with a broader clinical presentation and differential work up for acute
dyspnea.36 In a prospective, blinded, observational study consecutively enrolling a total of 2683
patients with symptoms of dyspnea in the ED, multiorgan POCUS was performed in addition to
routine PE evaluation (including confirmatory contrast CT scans). 36 Of these patients, 95 were
diagnosed with PE and 41 of those had a positive multiorgan POCUS exam yielding a sensitivity
of 40% and a specificity of 100%.36 It was also noted that multiorgan POCUS had higher
sensitivity and specificity to help in establishing alternative diagnoses in the differential for
dyspnea (including pneumothorax, pneumonia and pericardial effusion).36 Although multiorgan
POCUS did not perform well as a diagnostic tool for ruling in PE, it had high specificity for
helping to exclude PE as the underlying cause of dyspnea.
Other combinations of POCUS have also been investigated for the use of multiorgan
POCUS in detection of PE. In another study, designed similarly to Zanobetti et al, Lichtenstein
et al evaluated patients with a presenting symptoms of dyspnea using a dual POCUS exam (LUS
plus CUS) to study the accuracy of the previously described BLUE protocol.17, 36 A total of 260
patients received a dual POCUS examination in addition to standard diagnostic tests (including
helical CT for suspected PE).17 Among these patients, 21 received a diagnosis of PE with 20 of
those patients having a positive LUS exam and 17 having a positive CUS exam; when the
patients who had both positive LUS and CUS exams were considered, the dual POCUS exam
demonstrated a sensitivity of 81% with a specificity of 99%.17 The authors concluded this
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method is more advantageous in ruling out PE in that it also helps to find alternative etiologies
for patients presenting with symptoms of dyspnea and reported was able to correctly diagnosis
the underlying cause of respiratory compromise in 90.5% of patients to expedite management.17
This is yet another study that illustrates the value-added use of multiorgan POCUS in patients
with respiratory presentations that may or may not include PE.
In a similar study design, Bataille et al evaluated the use of an alternative dual POCUS
including LUS and cardiac ultrasound (echocardiography) in accurately diagnosing the cause of
acute respiratory failure (including symptoms of tachypnea, hypoxia on room air with respiratory
acidosis).37 Of the 136 patients presenting with symptoms of acute respiratory failure and
received the dual POCUS exam plus a standard diagnostic work up (including CT), 13 received a
final diagnosis of PE with five of those patients showing a positive dual POCUS exam yielding a
sensitivity of 83% and a sensitivity of 84%.37 The authors also performed sub-analysis in this
study for single organ LUS alone for comparison with a resulting sensitivity of 67% and
specificity of 94% and concluded that the dual approach was favorable compared to single LUS
for diagnosis of PE. 37 This study also demonstrated that this form of dual POCUS had greater
accuracy in diagnosis other etiologies such as cardiogenic edema and pneumonia. 37 When
considering both the results of Lichtenstein et and Bataille et al with a population of patients
presenting with symptoms possibly less specific for PE (i.e., acute respiratory failure), it still
resulted in similar suboptimal sensitivity for diagnosis of PE but provided a means to help rule
out PE and uncover other underlying etiologies to explain the cardiopulmonary pathology.
Another multiorgan POCUS combination that exists and has been investigated in the use
of diagnosing suspected PE is another dual modality of cardiac ultrasonography
(echocardiography) plus CUS. Three prospective observational studies evaluated the diagnostic
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accuracy of how this dual multiorgan POCUS compares to CTPA.23,33,34 Mansencal et al
attempted to evaluate if form of dual POCUS could help triage patients in the ED with suspected
PE and conducted a prospective, blinded, observational trial consecutively enrolling 76 patients
that presented to the ED with concern for PE after D-dimer screening was completed.33 All
patients received echocardiography plus CUS using a portable ultrasound device at the bedside
and measured for symptoms of RV strain as previously described and CUS for signs of DVT. 33
Of the patients enrolled, 31 patients had PE diagnosis with a majority confirmed by CTPA (only
three patients required an additional V/Q scan to confirm the diagnosis) and 41 patients had a
positive dual POCUS exam with a reported combined sensitivity of 87% and a specificity of
69%.33 To further evaluate the impact that more than one POCUS modality has on the accuracy
of PE diagnosis, the authors also reported single organ POCUS results for comparison with
echocardiography alone demonstrating a sensitivity of 55% and specificity of 69% while CUS
alone had a sensitivity of 58% with a specificity of 93%.33
In a similar prospective multicenter observational study evaluating the same multiorgan
combination described above, Dwyer et al used the FOCUS protocol, including TAPSE, for
cardiac ultrasound plus CUS in evaluating 199 patients with suspected PE that were undergoing
CTPA (but the number of detector rows in the CTPA was not specified in the study).23 The dual
POCUS exam was considered positive if the patient had any abnormal findings on either
modality of ultrasound. The prevalence of PE diagnosis in this group was 46 patients (26 with
peripheral PE compared to 20 with centrally located PE) and total of 42 patients had positive
POCUS findings (20 patients had a positive CUS, 22 had a positive FOCUS exam and 32
patients had either a positive CUS or FOCUS exam). 23 For those patients with a positive FOCUS
exam alone (single organ cardiac exam), the reported sensitivity was 48% and specificity was
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88% regardless of the location of the PE; however, in the “either” group when CUS was also
considered (multiorgan POCUS), the sensitivity for PE increased to 87% with a specificity of
69% regardless of location of PE.23 It was also reported in the text of the results section of this
article (no table summarizing data available) that when considering the location of the PE, the
sensitivity for the “either” group decreased to 46% for peripheral (distal) PE but increased to
100% for centrally (proximally) located PE.23 This suggests that the use of a POCUS strategy
that includes cardiac plus CUS helped to identify patients with DVT that may have gone
undiagnosed until they manifested as higher risk PE.
One final study worth inclusion in the comparison of cardiac POCUS studies, is that
performed by Filipiak-Strezecka et al recently in 2018.34 This prospective observational study
investigated the use of a multiorgan POCUS approach also including cardiac ultrasound and
CUS and utilized a pocket-size portable ultrasound device. 34 A total of 100 patients presenting to
the ED with 15 patients having a positive CUS exam, 59 patients had a positive cardiac
ultrasound exam showing RV enlargement and a total of 24 patients had confirmed PE diagnosis
by CTPA.34 In those patients who had both a positive CUS and cardiac ultrasound exam, the
reported sensitivity was 54% with a specificity of 100% as well as a positive predictive value for
PE of 100%; when data was analyzed for those with a positive CUS or a positive cardiac
ultrasound exam, the sensitivity was 92% with a specificity of 49%.34 The authors also analyzed
the sensitivity and specificity of each single organ POCUS modality for comparison and reported
54% and 97%, respectively, for CUS alone and 92% and 51%, respectively, for cardiac
ultrasound alone.34 It was also noted that when this exam was incorporated into the physical
assessment it took approximately five minutes to perform. 34 These results suggest that when this
exam is incorporated to the clinical assessment of a patient with suspected PE, it may help
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clinicians increase their suspicion early on for the diagnosis of PE and lead to expedited and
improvement of this disease.
METHODS
A literature search was conducted via the Augsburg Library search engine but included
libraries worldwide. Peer reviewed articles were requested in the search for primary literature.
Databases searched included MEDLINE, Science direct, Pubmed, Google Scholar and
UpToDate. Additionally, review articles that were commonly cited in the review of references
from other articles retrieved were obtained reviewed as well when not obtained through the
above search. Only articles available in English were utilized. Article titles and abstracts were
reviewed for inclusion of any type of POCUS (single organ or multiorgan) as well as CTPA in
the evaluation of POCUS; if details of either were not available in the abstract, articles were
obtained for more thorough examination to see if met this criteria for comparison and inclusion.
Search terms and abbreviations utilized in this research included: pulmonary embolism
(PE), point of care ultrasound (POCUS), computed tomography pulmonary angiography
(CTPA), lung ultrasound, multiorgan ultrasound, thoracic ultrasound, cardiac ultrasound,
diagnosis and sensitivity.
Studies included in the literature review included those performed in adult (> 18 years
old) human subjects and excluded animal studies in order to better apply findings to the general
population. Literature reviewed included systematic reviews, meta-analyses, prospective
observational studies, retrospective chart reviews and case reports.
DISCUSSION
Despite advances in imaging technology and the use of clinical algorithms to help guide
systematic diagnostic management of PE, it remains a disease that is frequently underdiagnosed,
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undertreated and a fatal complication of VTE. Currently multi-detector row CTPA remains the
gold standard given it has both high sensitivity and specificity but can still produce falsenegative results, has a lower sensitivity for peripheral (distal) PE, is not always readily available
and is contraindicated in some cases. Additionally, CTPA is only helpful when it is obtained and
the potential for an inaccurate clinical probability assessment exists that can lead clinicians away
from obtaining CTPA in those still with PE. Therefore, one could argue that any additional
diagnostic information that may add to the efficiency and accuracy (ruling in and/or ruling out)
of PE evaluation should be considered and further investigated.
Based on this review of existing literature investigating the use of single and multiorgan
POCUS in the diagnosis of PE, the sensitivity of both modalities varies considerably (see Table
3). Overall, both modalities still proved to have inferior sensitivity to CTPA. In single organ
POCUS studies for TUS/LUS, sensitivity ranged from 71-80% for single-row CTPA compared
to 61-90% with for multi-row CTPA (if omit the data from Acar et al since they did not provide
a combined sensitivity result for comparison). The lower range results for the multi-row CTPA
comparison may be explained by the findings Jiang et al reported in the previously mentioned
meta-analysis that when studies prior to 2000 were omitted in analysis the overall sensitivity was
lower likely due to the comparison to the more sensitive multi-row CTPA.32
It is difficult to compare results of multiorgan POCUS sensitivity across the board given
the different combinations of POCUS used. However, in the five studies reviewed that provided
analysis of the sensitivity of single organ POCUS modalities compared to that of combined
individual POCUS components, multiorgan POCUS had higher sensitivity for all five
studies.6,23,33,34,37 However, it should be noted that in the study done by Filipiak-Strezka et al, the
multiorgan POCUS did report a lower combined sensitivity of 52% for cardiac POCUS and CUS
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compared to individual component sensitivities of 92% for cardiac POCUS and 54% for CUS;
but, the overall sensitivity increased to 92% when cardiac POCUS or CUS were compared.34 Of
these five studies found investigating the use multiorgan POCUS in PE diagnosis, only the study
by Nazerian et al using a triple POCUS approach reported sensitivity and specificity that came
somewhat close to that of CTPA but still remained inferior (triple POCUS 90% and 86%,
respectively compared to the reported CTPA performance of 96-100% and of 97-98%,
respectively).2,3,6
The heterogeneity of studies performed not only in single organ but also multiorgan
POCUS studies also likely lends to the variable results. Not all studies enrolled patients in the
same manner with some using convenience samples and some not utilizing consecutive
enrollment lending to bias (see Table 3). In the studies by Bataille et al, they alternatively
enrolled patients with symptoms of “acute respiratory failure” (and possibly a lower initial
suspicion of PE initially?) and overall had lower prevalence of PE in the enrolled patients (10%)
with a reported sensitivity for single organ LUS to be 67% compared to multiorgan POCUS
(LUS plus cardiac) of 83%.37 Lichtenstein et al reported a similar sensitivity of 81% with similar
selection criteria and prevalence (8%) but utilized a multiorgan POCUS approach of LUS and
CUS (the BLUE protocol).17 This may suggest that even when there may be lower suspicion of
PE, POCUS may still have some value in helping to diagnose PE as the underlying etiology of
acute respiratory failure.
One critique to the design of those studies that included blinding of the POCUS
examiner. In these studies, the clinician performing the POCUS exam were nonradiology/cardiology clinicians that were usually not involved in the management of the patient
and were blinded to the CTPA results (oftentimes the exam was done prior to the CTPA or soon

POCUS vs CTPA and PE
31

thereafter without the results being available to the POCUS examiner). While important to avoid
having CTPA results influence the interpretation of the POCUS exam it would likely be
performed by the managing clinician with additional information about the clinical case and
could also alter the results.
The existing single organ POCUS studies also varied in size with a majority having
smaller sample sizes. However, when considering the two largest studies using TUS, Nazerian
et al and Mathis et al still only reported the sensitivity of TUS to be 61-74% with the higher
value from the Mathis et al study which used single row CTPA likely yielding a falsely elevated
reported sensitivity for LUS/TUS and also did not consecutively enroll patients possibly
contributing to bias in patient selection.6,26 These findings suggest that the sensitivity of TUS
alone at best may be consistent with that of single-row CTPA (which has now largely been
replaced anyway with improved multi-row detector CTPA) and cannot be recommended for
diagnostic purposes in PE.
The International Liaison Committee on Lung Ultrasound recognized the emerging value
that LUS can provide in the evaluation of PE in its published “International evidence-based
recommendations for point-of-care lung ultrasound” in 2012.38 In this document (which included
data analysis only through the October 2010), Volpicelli et al gave the following
recommendations to the following three statements pertaining to PE:
•

“Lung ultrasound should be used in the evaluation of lung consolidation because
it can differentiate consolidations due to pulmonary embolism, pneumonia, or
atelectasis.” (strong: level A)38
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•

“Lung ultrasound is an alternative diagnostic tool to computerized tomography in
diagnosis of pulmonary embolism when CT is contraindicated or unavailable.”
(strong: level A)38

•

“Lung ultrasound is a clinically useful diagnostic tool in patients with suspected
pulmonary embolism.” (strong: level B)38

These recommendations were published prior to the availability of some more recent studies
(including the larger study by Nazerian et al in 2014) and did not specify if LUS was evaluated
as single organ POCUS versus integrated into a multiorgan POCUS approach.6,38 No updates to
these guidelines were found in this literature search.
Cardiac POCUS alone has also shown variable performance in the diagnostic accuracy
for PE. In the studies reviewed for cardiac POCUS (echocardiography) to evaluate for RV
dysfunction, the sensitivity ranged from 48-92% and the specificity 51-97% depending on the
criteria used in the cardiac POCUS evaluation (which varied between studies) and the location of
the PE. The most promising results for applying cardiac POCUS into PE evaluation were in
those patients who presented with symptoms of shock or hypotension resulting from central PE.
Dwyer et al found that cardiac POCUS alone had a sensitivity of 90% in detecting central PE
(and 100% sensitivity when combined with CUS) but decreased to only 48% for all PE when
peripheral PE were included in analysis.23 In the most recent (2014) available version of the
“Guidelines on the diagnosis and management of acute pulmonary embolism” published by the
European Society of Cardiology (ESC), the use of echocardiography is not recommended in
those patients who are normotensive with lower risk PE probability; however, it does supports
the use for PE diagnosis in patients presenting with hemodynamic instability that are too unstable
to confirm diagnosis with CTPA to allow reperfusion therapy to be immediately initiated.39
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Given the mortality associated with central emboli, the use of cardiac POCUS for evaluation of
PE should be reserved for this patient population and may prove to have a significant impact on
mortality associated with PE.
Based on the literature available to date, neither single nor multiorgan POCUS can be
used as a first line diagnostic tool in the evaluation of PE. However, it has shown promise as an
adjunct to the gold standard of CTPA. In the studies in which patients received LUS or TUS as
part of either single or multiorgan POCUS, alternative etiology for the presenting symptoms
were often found in the cases where PE was not the cause. In a study by Koenig et al in 2014, 96
patients who presented with clinical suspicion of PE and were able (convenience sample) to
receive both a multiorgan POCUS exam (using the same triple approach by Nazerian et al in
2014; cardiac, TUS and CUS) and confirmatory CTPA were enrolled; of these patients, 12
(12.5%) had a positive diagnosis of PE, two (2%) were also positive for DVT and 54 (56%) had
an alternative diagnosis found on the triple POCUS exam to explain symptoms (which were
confirmed by CTPA as well).13 The Koenig et al study is discussed here rather than included in
the previous review of the literature as the authors, unfortunately, did not provide sensitivity data
for their triple POCUS diagnostic performance. Koenig et al estimated that in those patients who
had alternative diagnosis to PE or DVT found on triple POCUS (56%), those patients could have
avoided needing CTPA or even other pulmonary radiographs.13 Nazerian et al also reported that
when multiorgan (triple) POCUS was used in their study, they were able to detect an alternative
diagnosis in almost one-third of the patients.6 In both these studies, triple POCUS enhanced
diagnostic management of these patients by 1) providing additional clinical data that would not
have necessarily been obtained in a timely manner to help narrow in on the differential diagnosis
for presenting symptoms, and 2) those cases where the POCUS exam preceded CTPA, a
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theoretical reduction to the amount of radiation exposure. In fact, a specific endeavor entitled
the “Lung Ultrasound in the Critically Ill Favoring Limitation of Radiation” project (or LUCIFLR project) has been developed to utilize LUS to decrease bedside radiographies by one-third
and urgent CT by two-thirds in the next three decades.40
The use of multiorgan POCUS has also been investigated for how it can contribute more
objective data for application into the prediction rules. Two prospective, observational studies
have investigated how the integration of clinical data from multiorgan POCUS into the clinical
prediction rules might improve the diagnostic process for PE.11,34 In an blinded, observational
cohort multicenter diagnostic accuracy study conducted by Nazerian et al in 2017, the authors
calculated both the conventional Wells score (Ws) but also created and calculated an alternative
ultrasound Wells score (USWs) in which two questions were changed to include more objective
clinical signs obtained from a multiorgan POCUS exam with LUS and CUS. 11 The two
questions that were adjusted were as follows: “signs and symptoms of DVT” was changed to
“venous ultrasound positive for DVT” and “alternative diagnosis less likely than PE” was
changed to “alternative diagnosis less likely than PE after lung ultrasound.” 11 The scoring points
assigned to these statements was unaltered and diagnosis for PE was considered “unlikely” still if
the score was < 4 for either score.11 Of the 446 patients that were consecutively enrolled with
clinical suspicion of PE and were able to receive the multiorgan POCUS exam within three hours
(convenience sample), 125 patients were diagnosed with PE with a majority (119) by CTPA
(five required lung scintigraphy and one by autopsy). When the USWs was compared to the
standard Ws, it had a significantly improved sensitivity of 70% compared to 58% (p<0.01).
Furthermore, in those patients who had a USWs <4 and a negative D-dimer, the failure rate was
0.8% compared to 1.9% for Ws (although this difference did not meet statistical significance,
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p=0.33).11 It was estimated that when multiorgan POCUS (LUS and CUS) more objectively
adjusted the prediction rule (Wells score) and was combined with D-dimer, CTPA could have
been avoided 50.5% of patients compared to 27% of patients using the Ws.11
Filipiak-Strzecka et al also investigated how data from a multiorgan POCUS (cardiac and
CUS) using a pocket-sized ultrasound device to augment the physical exam, may be integrated
into both the Wells and Geneva prediction rules to improve the efficiency and diagnostic
accuracy for PE.34 These authors only adjusted the Wells rule for sign and symptoms of DVT to
include “positive CUS result” but added a criteria for RV enlargement (which could aware one
point to the score); for the Geneva score, “unilateral lower limb pain” was changed to “positive
CUS result” and the addition of RV enlargement was added in the same manner as the Wells
score.34 The threshold for the modified Wells score was changed to > 5 and >7 for the modified
Geneva score. The authors reported that there was a significant improvement in diagnostic
accuracy in the conventional versus modified Wells score (81% versus 93%, respectively;
p=0.012) as well as in the Geneva score (59% versus 94%, respectively; p=0.02).34 These two
studies demonstrate that multiorgan POCUS may have multiple roles in the diagnostic process
for PE. Based on the findings in these two studies, the ability of multiorgan POCUS to help add
to the risk stratification of patients presenting with clinical suspicion of PE appears promising.
One of the main drawbacks to the diagnostic evaluation of PE is that CTPA is not always
available and cannot be applied to some patient populations. In some of the reviewed studies on
both single and multiorgan POCUS, those patients with hemodynamic instability or pregnancy
were excluded and, based on this review of the literature, no studies are available looking at the
use of POCUS in these populations. As stated previously above, the International Liaison
Committee on Lung US recommendations does support the use of at least LUS as an alternative
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diagnostic tool when CTPA is unavailable or contraindicated. 38 Given the reported higher
sensitivity of triple POCUS, this seems to be the logical alternative for this patient population
and a case study reported in the literature illustrates this very point. Silva et al describe a case in
which a 26 year-old-man presented to the ED with sudden onset of dyspnea, pleuritic chest pain
and fatigue. 41 The patient had no previous medical history except for a recent upper airway
infection and essentially had been on bedrest for three days preceding. 41 His physical exam was
notable for tachypnea (respiratory rate of 24 breaths per minute), tachycardia (heart rate 115
beats per minute), oxygen saturations of 92%, a blood pressure of 138/79, crepitus in the left
lower lung base and swelling of his right leg with normal pulses. 41 A Wells score was calculated
to be nine (based on clinical signs and symptoms of DVT) and PE was the most probable
diagnosis. 41 However, CTPA was not available at the time of this patient’s presentation (for
reasons not specified). Therefore, the providers applied the triple POCUS protocol and found the
following: On LUS and A profile was observed on all right lung fields with some B-lines in the
anterior part of the lung base and a small sub-pleural consolidation in the more posterior
position; Cardiac evaluation did not show dilation of the RV nor any thrombi; CUS showed a
right popliteal thrombus.41 Given the finding of DVT on CUS with characteristics of PE per
LUS, the patient was immediately started on anticoagulation therapy and made a full recovery in
three days. 41
CONCLUSION
Pulmonary embolism remains a common condition that frequently is misdiagnosed or
goes undiagnosed with fatal consequences. When treated early, PE has a mortality rate of 2-8%
but if left untreated the mortality may be as high as 25-30%.32 Therefore, early and accurate
diagnosis is vital to allow initiation of anticoagulation therapy to appropriate candidates. The
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diagnosis of PE presents challenges to clinicians as the symptoms are non-specific. In the United
States, over 10 million patients seek care annually for the symptoms of dyspnea, chest pain or
both with the etiology of PE included in differential diagnosis for these symptoms.34 Currently,
multi-row CTPA remains the gold standard for diagnosis of PE due to its high sensitivity and
specificity for detection of PE. However, this imaging modality has limitations and cannot be
used in all patient scenarios. Furthermore, despite improvements in CTPA sensitivity and
algorithms to guide the diagnostic approach to PE, mortality for this disease remains unchanged
and new diagnostic techniques should be explored.2,5
Point-of-care ultrasound has a promising role in the evaluation of PE. However, based on
the literature available to date, the sensitivity of both single and multiorgan POCUS remains
inferior to CTPA and should not be used as a first line diagnostic test. Triple multiorgan
POCUS, using cardiac ultrasound (echocardiography), LUS and CUS, has shown sensitivity and
specificity closer to CTPA when compared to single organ POCUS and should be considered as
an alternative when the gold standard is unavailable or contraindicated.
Point-of-care ultrasound has several advantages in the evaluation of PE. First, POCUS is
a safe, non-invasive imaging modality that has no contraindications. Secondly, POCUS is
readily available for use at the bedside and can be efficiently integrated into the physical exam
and clinical assessment of a patient early on in admission. Objective information obtained from
POCUS can be incorporated into prediction rules to help improve diagnostic accuracy and
expedite management strategies for patients with suspected PE. Studies have demonstrated the
POCUS exam can be done in a timely manner with a minimum average time to complete some
exams being three minutes (Lichtenstein et al for combined LUS and CUS)17 and a maximum
time reported was 15 minutes (Mohn et al for TUS)25 in the studies reviewed but likely varies
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based on the experience of the clinician. Consideration should be given to include the use of
POCUS in algorithms that guide the diagnostic management of PE (see Figure 2 for an example
of one proposed algorithm). Third, POCUS can provide information to confirm alternative
cardiopulmonary conditions that present with symptoms like PE and narrow the differential
diagnosis and rule out PE. Given this potential, POCUS also has the potential to reduce the need
for unnecessary imaging. Fourth, POCUS provides an alternative diagnostic test for those
patients who may be too unsafe for transport for tests, have contraindications for CTPA or if
CTPA is not available. Lastly, as ultrasound technology improves, devices are becoming
increasingly compact and an inexpensive imaging option that is widely available for use.5
Despite the potential advantages of POCUS in the evaluation of PE, some issues exist
that limit the effectiveness and accuracy of this tool. Variability in training and experience in
those performing this exam likely will impact the accuracy of POCUS. While medical schools
are increasingly incorporating POCUS into their training, variability in curriculum and
competency exists among clinicians across different areas of practice.5,9,16 Furthermore, a need
for standardized and validated POCUS protocols exist as evidenced by the variability observed
in the literature for criteria defining a “positive” POCUS exam. Additional future opportunities
for research to help determine how POCUS could improve the diagnostic evaluation of PE could
include studies that use POCUS in those patient populations currently limited in their diagnostic
evaluation of PE and cannot receive CTPA; how the addition of multiorgan triple POCUS affects
the timeline of PE diagnosis, treatment initiation and outcomes; the impact multiorgan triple
POCUS could have on the prediction rules; and, how the use of POCUS performed by the
clinical care team privy to patient information would affect the sensitivity of the exam (i.e.,
reality). Until observational studies can consistently demonstrate that POCUS yields a high
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sensitivity and specificity to rival CTPA, POCUS cannot replace the gold standard CTPA for the
diagnosis of PE and randomized controlled trials cannot be safely performed to evaluate these
two modalities against one another.
The use of POCUS is seemingly evolving and expanding in multiple clinical facets not
just pertaining to PE. Given the compact size of devices as well as increasing use and research
available on how this tool can enhance the clinical assessment and patient outcomes, I anticipate
POCUS may soon become integrated into the routine physical exam in many areas of practice
outside the ED and ICU. In fact, PCOUS has even been described as an “ultrasound
stethoscope” or the “stethoscope of the 21 st century.”5 As a new physician assistant, it seems that
acquiring the skill of POCUS would not only enhance my clinical evaluation, but also help me in
providing accurate and efficient clinical management of my patients. The use of POCUS would
be a valuable adjunct or even alternative diagnostic tool in certain situations if I encounter a
patient with a PE or any other underlying cardiopulmonary condition. However, it also is
apparent that sufficient training, practice with this device and staying current with specific
literature pertaining to POCUS in various conditions seems to be crucial to the successful
application of POCUS into practice. In the words of Squizatto et al, “the new era of POCUS has
just started.”5
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APPENDIX
Table 1. Wells Score and Geneva Score clinical prediction rules for PE
Wells Score*
Variable
Alternative Dx less likely than PE
Clinical signs and Sx of DVT (leg
swelling and pain with palpation
of deep veins)

Points
3
3

Heart rate > 100 bpm

1.5

Immobilization for > 3 days or
surgery in previous 4 weeks
Previous PE or DVT
Hemoptysis
Cancer (with treatment in the past
6 months or palliative care)

1.5

Three-level clinical probability
assessment
(Wells criteria)
High

Score

Moderate
Low
Two-level clinical probability
assessment
(Modified Wells criteria)
PE likely
PE unlikely

1.5
1
1

Geneva Score**
Variable
Age > 65 years old
Pain on lower limb deep vein
palpitation and unilateral edema.

Points
1
4

Unilateral lower limb pain

3

Heart rate 75-94 bpm

3

Heart rate >95 bpm
Surgery or fracture within 1
month
Previous PE or DVT
Hemoptysis
Active malignancy

5
2

Three-level clinical probability
assessment

3
2
2
Score

>6

High

>11

2-6
<2

Moderate
Low

4-10
0-3

Two-level clinical probability
assessment

Score

Score
>4

PE likely

>6

<4

PE unlikely

0-5

Abbreviations: Sx (symptoms), DVT (deep vein thrombosis), Dx (diagnosis), bpm (beats per
minute), PE (pulmonary embolism)
*Adapted from Papadakis MA, McPhee SJ, Rabow MW. Current Medical Diagnosis and
Treatment. 57th ed. New York, NY: McGraw Hill Education; 2018: 303.
**Adapted from Righini M, Robert-Ebadi H, Le Gal G. Diagnosis of acute pulmonary embolism.
J Thromb Haemost 2017; 15: 1251–61
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Table 2. Ultrasound characteristics for pulmonary pathology15,17,20
Pulmonary
Condition
Pneumothorax

Ultrasound Characteristics

Pulmonary edema
or interstitial
syndrome.

Profuse, bilateral B+ lines (“lung
rockets”) with lung sliding and smooth
pleural morphology

Pneumonia or
acute respiratory
distress syndrome
(ARDS)

Focal B-lines with irregular pleural
morphology, consolidation that does not
invade the entire lobe (shred sign)

Pleural effusion

Anechoic area surrounded by typical
anatomic boundaries.

Pulmonary
embolism

Triangular or wedge-shaped or round
hypoechoic lesions, +/- pleural effusion,
A-lines with lung sliding.

Example ultrasound
images*

Absence of lung sliding (A lines) or
pulse combined with the presence of a
lung point.

Ultrasound images obtained from the following sources:
*
Patel CJ, Bhatt HB, Parikh SN, Jhaveri BN, Puranik JH. Bedside lung ultrasound in emergency
protocol as a diagnostic tool in patients of acute respiratory distress presenting to the emergency
department. J Emerg Trauma Shock. 2018; 11: 125-129.
http://www.onlinejets.org/article.asp?issn=09742700;year=2018;volume=11;issue=2;spage=125;epage=129;aulast=Patel Accessed July 25,
2019.
*Ericsoussi B. Thoracic ultrasound for diagnosing pulmonary embolism. SlideShare.
https://www.slideshare.net/basselericsoussi/thoracic-ultrasound-for-diagnosing-pulmonaryembolism. Published February 26, 2009. Accessed July 25, 2019.

Table 3. Summary of single organ and multiorgan POCUS sensitivity and specificity data
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Figure 1. Current Diagnostic Algorithm for Pulmonary Embolism.
Suspected PE

Clinical Probability Assessment
using Wells Score

Wells score <4
PE unlikely

Wells score >4
PE likely

D-dimer assay

(-) D-Dimer
PE excluded.
Search for
alternative Dx.

(+) D-Dimer

Normal CTPA

PE excluded.
Search for
alternative Dx.

Obtain CTPA

Indeterminate
CTPA

Positive CTPA

Obtain CUS or
PA

Dx established.
Begin anticoagulation
treatment.

Abbreviations: PE (pulmonary embolism), Dx (diagnosis), CTPA (computed tomography
pulmonary angiography), CUS (compression ultrasound), PA (pulmonary angiography)
Adapted from Papadakis MA, McPhee SJ, Rabow MW. Current Medical Diagnosis and
Treatment. 57th ed. New York, NY: McGraw Hill Education; 2018: 304.
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Figure 2. Proposed diagnostic algorithm for pulmonary embolism incorporating triple
multiorgan POCUS
Suspected PE

Clinical Probability Assessment
using Wells Score

Wells score <4
PE unlikely

Wells score >4
PE likely

D-dimer assay

Triple multiorgan
POCUS

(+) D-Dimer

(-) D-Dimer
PE excluded.
Search for
alternative Dx.

No alternative Dx
found on POCUS
and/or (+) D-Dimer

Alternative Dx found on
POCUS or (-) D-Dimer

Search for
alternative Dx

(+) for PE

(-) for PE

negative

CTPA

DVT absent

positive

DVT present

PE Dx confirmed
and begin
treatment

Abbreviations: PE (pulmonary embolism), Dx (diagnosis), POCUS (point-of-care ultrasound),
CTPA (computed tomography pulmonary angiography), CUS (compression ultrasound), PA
(pulmonary angiography), DVT (deep vein thrombosis)
Adapted from Nazerian P, Vanni S, Gigli C, et al. Accuracy of point-of-care multiorgan
ultrasonography for the diagnosis of pulmonary embolism. Chest. 2014;145(5):950-957.
doi:10.1378/chest.13-1087

